These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30713313)

  • 1. Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy.
    Onda A; Miyagawa S; Takahashi N; Gochi M; Takagi M; Nishino I; Suzuki S; Oishi C; Yaguchi H
    Intern Med; 2019 Jun; 58(11):1635-1638. PubMed ID: 30713313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of myasthenia gravis and myositis induced by pembrolizumab].
    Noda T; Kageyama H; Miura M; Tamura T; Ito H
    Rinsho Shinkeigaku; 2019 Aug; 59(8):502-508. PubMed ID: 31341124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of anti-titin antibody positive nivolumab-related necrotizing myopathy with myasthenia gravis].
    Isami A; Uchiyama A; Shimaoka Y; Suzuki S; Kawachi I; Fujita N
    Rinsho Shinkeigaku; 2019 Jul; 59(7):431-435. PubMed ID: 31243249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
    Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
    BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of sporadic late-onset nemaline myopathy associated with myasthenia gravis positive for anti-titin antibody and anti-Kv1.4 antibody].
    Kanatani M; Adachi T; Sakata R; Watanabe Y; Hanajima R
    Rinsho Shinkeigaku; 2020 Jul; 60(7):489-494. PubMed ID: 32536668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cases of clinical myasthenia gravis associated with pembrolizumab use in responding melanoma patients.
    Nguyen BH; Kuo J; Budiman A; Christie H; Ali S
    Melanoma Res; 2017 Apr; 27(2):152-154. PubMed ID: 27776019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab-induced myasthenia gravis: A fatal case report.
    March KL; Samarin MJ; Sodhi A; Owens RE
    J Oncol Pharm Pract; 2018 Mar; 24(2):146-149. PubMed ID: 28147928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of myasthenia gravis developed during pembrolizumab administration, suggesting an excitation-contraction connection disorder].
    Fukazawa R; Takezawa H; Tsuji Y; Noto Y; Banba M; Fujii A
    Rinsho Shinkeigaku; 2020 Jan; 60(1):37-40. PubMed ID: 31852868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in the treatment of pembrolizumab-induced myasthenia gravis.
    Crusz SM; Radunovic A; Shepherd S; Shah S; Newey V; Phillips M; Lim L; Powles T; Szlosarek PW; Shamash J; Rashid S
    Eur J Cancer; 2018 Oct; 102():49-51. PubMed ID: 30138772
    [No Abstract]   [Full Text] [Related]  

  • 10. Pembrolizumab-induced Myopathy with Anti-striated Muscle Antibodies Successfully Treated by Plasma Exchange.
    Takahashi S; Okabayashi K; Soejima I; Oniki A; Ishihara S; Tomimitsu H
    Intern Med; 2023; 62(23):3525-3530. PubMed ID: 38044116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pembrolizumab-associated ocular myasthenia gravis.
    Liu Q; Ayyappan S; Broad A; Narita A
    Clin Exp Ophthalmol; 2019 Aug; 47(6):796-798. PubMed ID: 30859689
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
    Stefanou MI; Komorowski L; Kade S; Bornemann A; Ziemann U; Synofzik M
    BMC Neurol; 2016 Sep; 16(1):172. PubMed ID: 27623618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen.
    Stergiou C; Lazaridis K; Zouvelou V; Tzartos J; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Behin A; Sharshar T; De Baets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Gilhus NE; Casasnovas Pons C; Pitha J; Jakubíkova M; Hanisch F; Bogomolovas J; Labeit D; Labeit S; Tzartos SJ
    J Neuroimmunol; 2016 Mar; 292():108-15. PubMed ID: 26943968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of anti-acetylcholine receptor antibody-positive ocular myasthenia gravis with anti-titin antibody and anti-Kv1.4 antibody positive inflammatory myopathy].
    Fuse K; Araki A; Morozumi S; Yasui K; Kazuta T; Noda S; Katsuno M
    Rinsho Shinkeigaku; 2023 Dec; 63(12):830-835. PubMed ID: 37989286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia triggered by immune checkpoint inhibitors: New case and literature review.
    Gonzalez NL; Puwanant A; Lu A; Marks SM; Živković SA
    Neuromuscul Disord; 2017 Mar; 27(3):266-268. PubMed ID: 28109638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti-programmed death 1 antibody.
    Shirai T; Kiniwa Y; Sato R; Sano T; Nakamura K; Mikoshiba Y; Ohashi N; Sekijima Y; Okuyama R
    Eur J Cancer; 2019 Jan; 106():193-195. PubMed ID: 30528803
    [No Abstract]   [Full Text] [Related]  

  • 17. Myasthenia gravis and myopathy after nivolumab treatment for non-small cell lung carcinoma: A case report.
    Kim JS; Nam TS; Kim J; Kho BG; Park CK; Oh IJ; Kim YC
    Thorac Cancer; 2019 Oct; 10(10):2045-2049. PubMed ID: 31436031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia and nitrofurantoin.
    Wasserman BN; Chronister TE; Stark BI; Saran BR
    Am J Ophthalmol; 2000 Oct; 130(4):531-3. PubMed ID: 11024434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of signs in ocular myasthenia gravis and correlation with acetylcholine receptor antibodies.
    Francis IC; Nicholson GA; Kappagoda MB
    Aust N Z J Ophthalmol; 1985 Nov; 13(4):395-9. PubMed ID: 3833299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory myasthenia gravis exacerbation triggered By pembrolizumab.
    Earl DE; Loochtan AI; Bedlack RS
    Muscle Nerve; 2018 Apr; 57(4):E120-E121. PubMed ID: 29193151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.